Infectious Disease

The AJMC® Infectious Disease compendium is a comprehensive resource for news and interviews about the viruses, bacteria, fungi, and parasites that create illness and outbreaks.

Latest News

CDC | Image credit: Tada Images - stock.adobe.com
CDC Vaccine Panel Meets for First Time After RFK Jr Expelled Former Members

June 25th 2025

Controversy surrounds the Advisory Committee on Immunization Practices’ (ACIP) first meeting under new leadership as vaccine skeptics join the panel.

MMR vaccine vial - Leigh Prather - AdobeStock_283415438.jpeg
Falling Vaccination Rates May Bring Back Measles, Polio in US

June 24th 2025

Mental health recovery | Image Credit: Maggie L. Shaw/sora.chatgpt.com
Prolonged Mental Health Recovery Linked to Long COVID

June 10th 2025

One dose of the MMR vaccine provides 95% protection against measles, and 2 doses of the MMR vaccine are 97% effective against measles. - Image Credit: Leigh Prather - stock.adobe.com
CDC Urges All International Travelers to Be Vaccinated Against Measles

June 3rd 2025

nikitos - stock.adobe.com
ACP Experts Say FDA, CDC Moves May Undermine COVID-19 Vaccine Coverage for Millions

June 2nd 2025

Advancing UTI Treatment: Highlights from IDWeek 2024

Discover groundbreaking research on urinary tract infections, including findings from the EAGLE-2 and EAGLE-3 trials. Learn how gepotidacin, a first-in-class oral therapy, addresses antimicrobial resistance and unmet needs in UTI management.

AJMC Post Conference Perspective logo
Continuing Medical Education
View All
June 26th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
June 26th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Expert on C. Difficile
December 16th 2021

Payer Perspectives on Risk Stratification for CDI Recurrence

Neil Minkoff, MD Dale N. Gerding, MD Jessica Allegretti, MD, MPH Kevin U. Stephens, Sr, JD, MD Karina Abdallah, PharmD
Payer participants consider how they proactively risk stratify patients for clostridium difficile infection recurrence.
WWR banner
December 16th 2021

What We’re Reading: Moderna Vaccine Efficacy Reduced; Vaccine Mandate Revived; New Combo Against Breast Cancer

AJMC Staff
Two doses of the Moderna COVID-19 vaccine have reduced efficacy against the Omicron variant; a federal appeals court reinstates the Biden administration’s health care worker vaccine mandate in 26 states; a new combination therapy may reduce breast cancer progression.
Expert on C. Difficile
December 16th 2021

Bezlotoxumab Use in Patients at High Risk for CDI Recurrence

A brief review of the role of bezlotoxumab therapy for patients at high risk for clostridium difficile infection recurrence.
Expert on C. Difficile
December 9th 2021

Defining Value in Recurrent CDI

Neil Minkoff, MD Dale N. Gerding, MD Jessica Allegretti, MD, MPH Kevin U. Stephens, Sr, JD, MD Karina Abdallah, PharmD
An overview on how the cost of therapy for recurrent clostridium difficile infection may impact treatment planning.
Experts on C. Difficile
December 9th 2021

Practical Considerations for Fidaxomicin Use in Recurrent CDI

Neil Minkoff, MD Dale N. Gerding, MD Jessica Allegretti, MD, MPH Kevin U. Stephens, Sr, JD, MD Karina Abdallah, PharmD
Focused discussion on the use of fidaxomicin for clostridium difficile infection, and possible barriers to the selection of this agent.
Dr Leslie Kantor on Responding to Misinformation About Flu Vaccines
December 3rd 2021

Dr Leslie Kantor on Responding to Misinformation About Flu Vaccines

Misinformation about flu vaccines must be dealt with immediately, according to Leslie Kantor, PhD, MPH, chair and professor of the Department of Urban-Global Public Health, Rutgers School of Public Health.
Experts on C. Difficile
December 2nd 2021

Payer Perspectives on Coverage Criteria for Clostridium Difficile Treatments

Neil Minkoff, MD Dale N. Gerding, MD Jessica Allegretti, MD, MPH Kevin U. Stephens, Sr, JD, MD Karina Abdallah, PharmD
Payer participants break down how coverage criteria are determined for treatments for clostridium difficile infection.
Expert on C Difficile Infection
December 2nd 2021

Treatment Guidelines and Recommendations for C. Diff Infection

Neil D. Minkoff, MD Dale N. Gerding, MD Jessica Allegretti, MD, MPH Kevin U. Stephens, Sr, JD, MD Karina Abdallah, PharmD
Shared insight on the differences between ACG and IDSA/SHEA treatment guidelines for patients with clostridium difficile infection.
pregnant woman
November 29th 2021

Maternal STIs Linked With Increased Risk of Preterm Birth

Gianna Melillo
Results of a nationwide retrospective cohort study show maternal infection with syphilis, gonorrhea, or chlamydia was associated with an increased risk of preterm birth.
Vaccine
November 24th 2021

GAO Report: Policies to Incentivize Vaccine Development and Investment

Hayden E. Klein
The report briefly explained the policy options that policymakers can use to help address challenges related to vaccine research and development, testing, and manufacturing, as well as the economic challenges related to vaccine development for infectious diseases.
Experts on C. Difficile Infection
November 24th 2021

Identifying Treatment Goals for Recurrent CDI

Neil D. Minkoff, MD Dale N. Gerding, MD Jessica Allegretti, MD, MPH Kevin U. Stephens, Sr, JD, MD Karina Abdallah, PharmD
A panel of experts review treatment goals and assessing response in patients with recurrent clostridium difficile infection.
Experts on C. Difficile Infection
November 24th 2021

Impact of Recurrent CDI on Patients and the Healthcare System

Neil D. Minkoff, MD Dale N. Gerding, MD Jessica Allegretti, MD, MPH Kevin U. Stephens, Sr, JD, MD Karina Abdallah, PharmD
A broad view on the impact of recurrent clostridium difficile infection on patients and the healthcare system at large.
Enhanced image of C difficile bacteria
November 22nd 2021

Infection Prevention Practices, Frontline Education Led to Decrease in C difficile Infections

Lauren Massaro
A multifaceted approach focused on enforcing basic infection prevention practices and promoting education about Clostridioides difficile (C difficile) transmission led to a reduction in the number of infections in a hospital setting.
COVID-19
November 19th 2021

FDA Approves COVID-19 Boosters for All Adults

Allison Inserro
The FDA decision was followed by a CDC advisory panel meeting Friday, and as expected, CDC Director Rochelle Walensky, MD, MPH, who has spoken in favor of booster shots, signed off on the plan.
Experts on clostridium difficile infection
November 18th 2021

Recurrent CDI: Risk Factors and Outcomes

Neil Minkoff, MD Dale N. Gerding, MD Jessica Allegretti, MD, MPH Kevin U. Stephens, Sr, JD, MD Karina Abdallah, PharmD
Experts focus on recurrent clostridium difficile infection to define risk factors and discuss impact on patient outcomes.
Experts on clostridium difficile infection
November 18th 2021

Defining Traditional Risk Factors for Developing C. Diff Infection

Neil Minkoff, MD Dale N. Gerding, MD Jessica Allegretti, MD, MPH Kevin U. Stephens, Sr, JD, MD Karina Abdallah, PharmD
Opening their discussion, panelists elucidate patient factors that may impact risk of developing clostridium difficile infection.
Leslie Kantor, PhD, MPH
November 12th 2021

Dr Leslie Kantor on Communicating Importance of Receiving Both Flu, COVID-19 Vaccines

Leslie Kantor, PhD, MPH, chair and professor of the Department of Urban-Global Public Health, Rutgers School of Public Health, discusses the key messages that people need to hear about the continued importance of the flu vaccine, even if they have been immunized for COVID-19.
Email being sent
November 11th 2021

What We’re Reading: Measles Outbreaks Possible; NIH vs Moderna; Mental Health Benefits Expand

AJMC Staff
The World Health Organization and CDC warn of the potential for measles outbreaks; the National Institutes of Health (NIH) and Moderna battle over patent rights to Moderna’s COVID-19 vaccine; a new Kaiser Family Foundation shows employers have increased mental health care offerings.
Review Clarifies Pediatric Treatment of CDI
November 4th 2021

Review Recommends Options for Pediatric Treatment of Clostridioides difficile Infection

Tony Hagen
Evidence is insubstantial for treatment of Clostridioides difficile infection (CDI), but authors of a review of available evidence provide recommendations for agents and testing.
What We're Reading
November 3rd 2021

What We’re Reading: CDC Recommends Pfizer Vaccine for Younger Children; Drug Price Reform Agreement; Vaccination Status and Death Benefits

AJMC Staff
The CDC director endorsed a pediatric Pfizer COVID-19 vaccine for children aged 5 to 11 years; proposed drug pricing reform will allow Medicare Part D to negotiate directly with pharmaceutical companies; some employers may not send death benefits to families of employees who die of COVID-19 without being vaccinated.
Peter Hotez, MD, PhD, FASTMH, Baylor College of Medicine
October 30th 2021

Dr Peter Hotez on the Urgent Need for a COVID-19 Vaccine for Children

Maggie L. Shaw
Peter Hotez, MD, PhD, FASTMH, professor of pediatrics and molecular virology and dean, National School of Tropical Medicine, Baylor College of Medicine, and codirector, Texas Children’s Hospital Center for Vaccine Development, addresses the approval of the Pfizer/BioNTech COVID-19 vaccine for children aged 5 to 11 and emphasized its benefits far outweigh the rare possibility of myocarditis.
FDA Issues EUA for COVID-19 Vaccine for Children
October 29th 2021

FDA Issues EUA for COVID-19 Vaccine for Children

Allison Inserro
In a long-awaited move, the FDA approved a pediatric dose of Pfizer/BioNTech's COVID-19 vaccine for children aged 5 to 11 years.
Investigators Elucidate Outcomes and Costs in CDI
October 27th 2021

Investigators Elucidate Outcomes and Costs in CDI

Tony Hagen
In studies presented at the American College of Gastroenterology 2021 meeting, success was reported for RBX2660, a treatment for clostridioides difficile infection (CDI).
Emerging Antibiotic Resistance Predicted With Machine Learning
October 24th 2021

Emerging Antibiotic Resistance Predicted With Machine Learning

AJMC Staff
Many novel traits are shared through gene transfer, but scientists haven’t been able to determine why some bacteria engage in gene transfer while others do not.
c diff image
October 23rd 2021

Study Identifies Possible Molecular Target for Clostridioides difficile Infection Therapies

AJMC Staff
A study funded by the National Institutes of Health found that Glucosyltransferase domain is a possible molecular target for therapeutic interventions for Clostridioides difficile infection.
Trials Support Interchangeability of Merck’s V114 Vaccine With PCV13 in Infants for Pneumococcal Disease
October 7th 2021

Trials Support Interchangeability of Merck’s V114 Vaccine With PCV13 in Infants for Pneumococcal Disease

Hayden E. Klein
Research presented during IDWeek 2021 showed data on V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine.
WWR banner
October 7th 2021

What We’re Reading: FDA to Decide on Pediatric COVID-19 Vaccine; WHO Endorses Malaria Vaccine; Texas Abortion Law Blocked

AJMC Staff
Pfizer and BioNTech ask FDA to authorize their COVID-19 vaccine in children; the World Health Organization (WHO) recommended widespread use of the world’s first malaria vaccine; a US judge blocks Texas’ strict abortion law.
Shoe Soles Are a Major Cause of C difficile Transmission
October 1st 2021

Shoe Soles Are a Major Cause of C difficile Transmission

Hayden E. Klein
Samples from 12 countries suggest shoe soles have a high positivity rate for Clostridium difficile, a strain primarily thought of as a hospital-associated infection.
Bacteria
October 1st 2021

Research Highlights Effect of New Biotherapeutic on Clostridioides difficile Infection

Hayden E. Klein
New research presented at IDWeek 2021 presented data on the microbiota-based live biotherapeutic RBX2660 for recurrent Clostridioides difficile infection.
Doctors in hospital corridor
September 27th 2021

Readmission Common Following CDI Hospitalization, Study Finds

Jared Kaltwasser
When patients are quickly readmitted, they have higher health care costs, a new study has found.
<1
...
567891011>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo